Zobrazeno 1 - 10
of 96
pro vyhledávání: '"B. Ehlken"'
Publikováno v:
Revista de neurologia. 73(11)
Risk minimisation measures for valproate were implemented in Spain in 2015.The objective of this study is to assess the effectiveness of valproate risk minimisation measures in Spain intended to decrease the use of valproate as a first-line therapy,
Autor:
C. Siffel, M. Page, T. Maxwell, B. Thun, N. Kolb, B. Ehlken, M. Rosenlund, D. Von Bredow, J. Keja
Publikováno v:
European Neuropsychopharmacology. 29:S551
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 138:119-125
Fragestellung: Die vorliegende Arbeit vergleicht die Kosteneffektivitat von Roflumilast plus langwirksamem Beta-2-Agonisten (LABA) mit einer LABA-Monotherapie bei Patienten mit schwerer und sehr schwerer COPD in Deutschland. Methode: Die Kosteneffekt
Autor:
B. Ehlken, M Thalheimer, H. Knoth, Ulrich Schuler, Torsten Hoppe-Tichy, Helmut Ostermann, Christina Rieger, Michael G. Kiehl, Oliver A. Cornely, Andrew J. Ullmann
Publikováno v:
Mycoses. 55:514-520
Invasive fungal disease (IFD) causes increasing morbidity and mortality in haematological cancer patients. Reliable cost data for treating IFD in German hospitals is not available. Objective of the study was to determine the institutional cost of tre
Publikováno v:
Journal of Medical Economics. 15:155-165
This retrospective patient data analysis was initiated to describe current treatment patterns of patients in Germany with arterial hypertension, with a special focus on compliance, persistence, and medication costs of fixed-dose and unfixed combinati
Publikováno v:
Acta Paediatrica. 91:769-775
UNLABELLED The aim of this study was to collect representative data on the incidence and clinical characteristics of community-acquired acute gastroenteritis (AGE) due to rotavirus (RV) in German children up to 4 y of age. In 20 paediatric practices
Publikováno v:
Value in Health. 18(7)
Publikováno v:
Aktuelle Dermatologie. 31:321-327
Autor:
A. Smala, Stefan N. Willich, B. Ehlken, H.-J. Rupprecht, K. Berger, H. C. Diener, Bernd Brüggenjürgen, M. Spannagl
Publikováno v:
Journal of Public Health. 13:216-224
As of January 2004, a new DRG (diagnosis related groups) based system has been introduced for the reimbursement of hospital services in Germany. As current data on the treatment cost of patients with myocardial infarction (MI), ischaemic stroke (IS),
Publikováno v:
Value in Health. 17(7)